Table 2.

Comparison of the characteristics of ERV- and/or TGC-resistant clinical isolates.

Strains (n = 24)	ERV MIC (mg/L)	TGC MIC (mg/L)	Gender	Age (year)	Source	Department	Outcomes	MLST	Resistance gene
Only ERV-resistant group (n = 2)
CRAB-18a	8	2	Female	50	Wound secretion	Intensive Care Unit	Cure	208	blaOXA-23, blaOXA-24, blaOXA-51
CSAB-211	8	4	Male	31	Wound secretion	Department of Trauma and Orthopedics	Cure	208	bla OXA-51
Both ERV- and TGC-resistant group (n = 7)
CRAB-42	8	16	Male	60	Sputum	Intensive Care Unit	Cure	208	blaOXA-23, blaOXA-24, blaOXA-51
CRAB-105	8	16	Male	79	Wound secretion	Department of General Family Medicine	Cure	208	blaOXA-23, blaOXA-58, blaOXA-51
CRAB-133	16	32	Male	88	Sputum	Intensive Care Unit	Cure	208	blaOXA-23, blaOXA-24, blaOXA-51
CRAB-177	8	32	Female	78	Wound secretion	Department of Neurology	Cure	1486	blaOXA-23, blaNDM-1, blaOXA-51
CRAB-194	8	16	Male	75	Sputum	Intensive Care Unit	Death	208	blaOXA-23, blaVIM, blaOXA-51
CSAB-45	8	8	Male	65	Blood	Department of Gastrointestinal Surgery	Cure	208	bla OXA-51
CSAB-107	8	16	Male	47	Sputum	Intensive Care Unit	Cure	191	blaOXA-24, blaOXA-51
Only TGC-resistant group (n = 15)
CRAB-35	2	16	Male	81	Wound secretion	Intensive Care Unit	Cure	208	blaOXA-23, blaOXA-24、blaOXA-51
CRAB-61	2	32	Male	68	Wound secretion	Department of Neurosurgery	Cure	191	blaOXA-23, blaOXA-24、blaOXA-51
CRAB-86	2	8	Male	63	Sputum	Department of Rheumatology	Cure	208	blaOXA-23, blaOXA-51
CRAB-110	0.25	8	Male	44	Cerebrospinal fluid	Department of Neurosurgery	Cure	208	blaOXA-23, blaOXA-24、blaOXA-51
CRAB-123	1	16	Male	78	Sputum	Intensive Care Unit	Cure	208	blaOXA-23, blaOXA-24、blaOXA-51
CRAB-145	0.5	8	Female	62	Urine	Department of Neurology	Cure	1849	blaOXA-23, blaOXA-24、blaOXA-51
CRAB-158	1	16	Male	68	Sputum	Intensive Care Unit	Cure	208	blaOXA-23, blaOXA-51
CRAB-161	0.5	16	Male	82	Sputum	Intensive Care Unit	Death	208	blaOXA-23, blaOXA-24、blaOXA-51
CRAB-167	0.12	8	Male	77	Sputum	Intensive Care Unit	Death	208	blaOXA-23, blaOXA-24、blaOXA-51
CRAB-185	2	16	Male	48	Sputum	Intensive Care Unit	Cure	208	blaOXA-23, blaVIM, blaOXA-51
CSAB-79	0.12	8	Male	46	Blood	Department of Blood Purification	Cure	2211	blaOXA-24, blaOXA-51
CSAB-93	2	8	Male	69	Sputum	Department of Oncology	Cure	451	bla OXA-51
CSAB-166	2	8	Male	68	Wound secretion	Department of Burn Plastic Surgery	Cure	208	bla OXA-51
CSAB-172	0.12	8	Male	71	Wound secretion	Department of Dermatology	Cure	208	bla OXA-51
CSAB-199	1	16	Male	56	Pleural effusion	Cardio-thoracic Surgery	Cure	208	blaOXA-24, blaOXA-51

^aCRAB: Carbapenem-resistant A. baumannii, CSAB: Carbapenem-susceptible A. baumannii.